Search Results - "Kubatzki, F"

Accelerated partial breast irradiation using 3D conformal radiotherapy: Toxicity and cosmetic outcome by Gatti, M, Ponzone, R, Bresciani, S, Panaia, R, Kubatzki, F, Maggiorotto, F, Di Virgilio, M.R, Salatino, A, Baiotto, B, Montemurro, F, Stasi, M, Gabriele, P

“…Abstract Purpose The aim of this paper is to analyze the incidence of acute and late toxicity and cosmetic outcome in breast cancer patients submitted to…”
Get full text

Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors by Biglia, N., Torta, Riccardo, Roagna, R., Maggiorotto, F., Cacciari, F., Ponzone, R., Kubatzki, F., Sismondi, P.

“…: To evaluate the efficacy and tolerability of long-term treatment with venlafaxine at low dose for the reduction of vasomotor symptoms in breast cancer…”
Get full text

Clinical outcome of adjuvant endocrine treatment according to PR and HER-2 status in early breast cancer by Ponzone, R, Montemurro, F, Maggiorotto, F, Robba, C, Gregori, D, Jacomuzzi, ME, Kubatzki, F, Marenco, D, Dominguez, A, Biglia, N, Sismondi, P

“…Patients with estrogen receptor (ER)+/progesterone receptor (PR)− and/or HER-2 overexpressing breast carcinomas may derive lower benefit from endocrine…”
Get full text

Sentinel node dissection as definitive treatment for node negative breast cancer patients by Ponzone, R, Biglia, N, Maggiorotto, F, Kubatzki, F, Elia, O, De Rosa, G, Sismondi, P

“…Aims: Negative sentinel node may predict tumour-free axillary nodes in breast cancer. We report the performance of sentinel node dissection at our Institution…”
Get full text

Abstract P1-09-21: Clinical evaluation of miR-100 as a predictor of endocrine-responsiveness in hormone-receptor positive breast cancer by Zucchini, G, Petrelli, A, Kubatzki, F, Cargnelutti, M, Di Virgilio, MR, Sarotto, I, Martincich, L, Ponzone, R, Martinello, R, Sapino, A, Nuzzo, A, Giordano, S, Montemurro, F

“…Abstract Background: Micro RNAs (miRNAs) are short, non-coding RNA molecules that act as negative regulators of gene-expression, mainly at the…”
Get full text

P3-07-04: Does Omission of Axillary Dissection after a Positive Sentinel Node Biopsy Influence Indication to Adjuvant Chemotherapy in Operable Breast Cancer Patients? by Montemurro, F, Maggiorotto, F, Valabrega, G, Kubatzki, F, Rossi, V, Marocco, F, Magistris, A, Gatti, M, Sarotto, I, Aglietta, M, Ponzone, R

“…Abstract Introduction: Based on the recently published ACSOG Z0011 study (JAMA 2011;305:569), axillary dissection (AD) may be avoided in breast cancer (BC)…”
Get full text